Neil Chheda
@neilc122
Another tech company replacing me, this time as chief snacks officer of Romulus Capital techcrunch.com/2017/08/17/zer…
china crispr patients: 86, US crispr patients: 0. It's clearly not just the long hours that make this possible, but doesn't hurt @krishnakgupta wsj.com/articles/china… via The Wall Street Journal